VIVS – vivosim labs, inc. (US:NASDAQ)
Stock Stats
News
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China [Yahoo! Finance]
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
VivoSim Labs (NASDAQ:VIVS) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
Form 10-Q VivoSim Labs, INC. For: Dec 31
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Cohen Douglas Jay
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Murphy Keith
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Milhous Alison Tjosvold
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Gobel David
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.